SEC Settles Insider Trading Suit Against Biotech Investor

Дата публикации: 16-06-2026 18:36:29

The U.S. Securities and Exchange Commission announced on Tuesday that a Texas-based investor will pay over $240,000 to settle the agency's claims he improperly traded stocks on insider information by buying shares of a public biotech firm ahead of its 2020 merger with a privately held biotechnology company.

Классификация: Экономика

Схожие новости

#	Наименование новости	Тональность	Информативность
1	Microchip Co. Strikes Deal In Decade-Old Severance Dispute	0	0
2	Musk Fights Uphill To Toss Fraud Verdict Of Twitter Buyout	0	0
3	Before SpaceX IPO, investors in China secretly acquired stakes	0	0
4	Biotech stock sends Wall Street surprising signal	0	0
5	Apple Device Software Co. Investor Sues Over Sale Records	0	0
6	Прокуратура США требует от россиянина Винника и биржи ВТС-е выплатить $100 млн	0	0
7	SEC debuts ‘Project Crypto' to bring U.S. financial markets ‘on chain'	0	0
8	DeepSeek's Valuation Soars To $50B, Plus More Rumors	0	0
9	Stockholders Tell Chancery Broadband Buyout Was Lowballed	0	0
10	3 Firms Guide Quantum Tech Co. EigenQ's $3B SPAC Merger	0	0

• Тональность 0
• Информативность 0
• www.law360.com